Retinal function and CFH-ARMS2 polymorphisms analysis: a pilot study in Italian AMD patients

Neurobiology of Aging
Ettore CapoluongoBenedetto Falsini

Abstract

Two major susceptibility genes, complement factor H (CFH) and age-related maculopathy susceptibility 2 (ARMS2), have been implicated in age-related macular degeneration (AMD) pathogenesis. We analyzed the association between CFH rs1061170 and/or ARMS2 rs10490924 polymorphisms with central retinal function properties, as evaluated by focal electroretinogram (fERG). Forty early AMD patients, with preserved visual acuity and typical macular lesions, underwent fERG recording (in response to 41 Hz flicker stimuli presented to the central 18 degrees) and CFH/ARMS2 genotyping. Mean fERG amplitude and sensitivity decreased in patients carrying CFH rs1061170 polymorphism (p < 0.01), compared with wild type ones, although visual acuity and funduscopic features were similar across the 2 groups. No significant fERG phase changes were observed. No association was detected between ARMS2 (rs10490924) polymorphism and fERG parameters. Our findings indicate that CFH (rs1061170) polymorphism impacts significantly on retinal function in early AMD patients, and support the hypothesis that dysfunctional CFH might result in early retinal function loss due to a reduction in the immune antioxidant defense mechanism.

References

Jul 1, 1991·Ophthalmology·R KleinL Hubbard
Jan 1, 1986·American Journal of Optometry and Physiological Optics·W H SeipleC Mayron
Oct 1, 1984·Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society·J I NelsonR E Carr
Mar 1, 1996·Journal of the Optical Society of America. A, Optics, Image Science, and Vision·W Seiple, K Holopigian
Jan 20, 1999·Vision Research·G R JacksonC D Finley
Mar 12, 2005·Science·Jonathan L HainesMargaret A Pericak-Vance
Mar 12, 2005·Science·Albert O EdwardsLindsay A Farrer
Mar 12, 2005·Science·Robert J KleinJosephine Hoh
May 5, 2005·Proceedings of the National Academy of Sciences of the United States of America·Gregory S HagemanRando Allikmets
Aug 5, 2005·American Journal of Human Genetics·Johanna JakobsdottirMichael B Gorin
Sep 22, 2007·Proceedings of the National Academy of Sciences of the United States of America·Atsuhiro KandaAnand Swaroop
Sep 27, 2007·Ophthalmic Epidemiology·Ronald Klein
Oct 9, 2007·Proceedings of the National Academy of Sciences of the United States of America·Peter J CoffeyJohn Greenwood
Oct 18, 2007·Proceedings of the National Academy of Sciences of the United States of America·Jonathan L HainesMargaret A Pericak-Vance
May 31, 2008·Nature Genetics·Lars G FritscheBernhard H F Weber
Jun 28, 2008·Nature Genetics·Rando Allikmets, Michael Dean
Apr 14, 2010·Survey of Ophthalmology·Larry A DonosoHelena Kuivaniemi
Apr 14, 2010·Proceedings of the National Academy of Sciences of the United States of America·Benjamin M NealeJohanna M Seddon
Aug 7, 2010·Investigative Ophthalmology & Visual Science·Benedetto FalsiniSilvia Bisti
Aug 17, 2011·Proceedings of the National Academy of Sciences of the United States of America·Alex JonesYingbin Fu
Jun 19, 2012·Clinical Chemistry and Laboratory Medicine : CCLM·Enrica MelloEttore Capoluongo

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Alternative Complement Pathway

The Alternative Complement Pathway is part of the innate immune system, and activation generates membrane attack complexes that kill pathogenic cells. Discover the latest research on the Alternative Complement Pathway.

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.